Arboretum launches precision medicine platform with $30m Series A
Arboretum, a new molecular information company, launched with a $30 million Series A financing round led by F-Prime, GV, and 406 Ventures, alongside Hims & Hers and Amgen. The company aims to expand access to genetic testing for common diseases and use AI to aid drug developers.